Distinct TH1 and TH2 cellular responses associated with malaria protection and risk in RTS,S/AS01E vaccinees (Q39262417)

10 September 2017

title

Distinct TH1 and TH2 cellular responses associated with malaria protection and risk in RTS,S/AS01E vaccinees (English)

1 reference

10 September 2017

0 references

1 reference

Diana Barrios

9

0 references

Héctor Sanz

Héctor Sanz

6

0 references

Gemma Moncunill Piñas

Gemma Moncunill

1

0 references

Ruth Aguilar

Ruth Aguilar

4

0 references

Jahit Sacarlal

Jahit Sacarlal

14

0 references

Benjamin Mordmüller

17

Benjamin Mordmüller

1 reference

10 September 2017

13

Salim Abdulla

1 reference

10 September 2017

19

John J Aponte

1 reference

10 September 2017

20

Claudia Daubenberger

1 reference

10 September 2017

21

Clarissa Valim

1 reference

10 September 2017

Maxmillian Mpina

2

1 reference

10 September 2017

Augusto J Nhabomba

3

1 reference

10 September 2017

Aintzane Ayestaran

5

1 reference

10 September 2017

Joseph J Campo

7

1 reference

10 September 2017

Chenjerai Jairoce

8

1 reference

10 September 2017

Yan Dong

10

1 reference

10 September 2017

Núria Díez-Padrisa

11

1 reference

10 September 2017

José F Fernandes

12

1 reference

10 September 2017

Nana A Williams

15

1 reference

10 September 2017

Jaroslaw Harezlak

16

1 reference

10 September 2017

Selidji T Agnandji

18

1 reference

10 September 2017

Carlota Dobaño

22

1 reference

10 September 2017

language of work or name

English

0 references

publication date

13 May 2017

1 reference

Clinical Infectious Diseases

10 September 2017

published in

1 reference

A phase 3 trial of RTS,S/AS01 malaria vaccine in African infants

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

First results of phase 3 trial of RTS,S/AS01 malaria vaccine in African children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Efficacy and safety of RTS,S/AS01 malaria vaccine with or without a booster dose in infants and children in Africa: final results of a phase 3, individually randomised, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Plasmodium falciparum-specific cellular immune responses after immunization with the RTS,S/AS02D candidate malaria vaccine in infants living in an area of high endemicity in Mozambique

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Induction of Plasmodium falciparum-specific CD4+ T cells and memory B cells in Gabonese children vaccinated with RTS,S/AS01(E) and RTS,S/AS02(D)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

T cell responses to the RTS,S/AS01e and RTS,S/AS02D malaria candidate vaccines administered according to different schedules to Ghanaian children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Circumsporozoite-specific T cell responses in children vaccinated with RTS,S/AS01E and protection against P falciparum clinical malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

A statistical interaction between circumsporozoite protein-specific T cell and antibody responses and risk of clinical malaria episodes following vaccination with RTS,S/AS01E

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Randomized, double-blind, phase 2a trial of falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults: safety, efficacy, and immunologic associates of protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Efficacy and safety of the RTS,S/AS01 malaria vaccine during 18 months after vaccination: a phase 3 randomized, controlled trial in children and young infants at 11 African sites

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Genetic Diversity and Protective Efficacy of the RTS,S/AS01 Malaria Vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Chemokine receptor expression identifies Pre-T helper (Th)1, Pre-Th2, and nonpolarized cells among human CD4+ central memory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Hierarchical IL-5 expression defines a subpopulation of highly differentiated human Th2 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Pre-clinical evaluation of new adjuvant formulations to improve the immunogenicity of the malaria vaccine RTS,S/AS02A.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

The expanding role(s) of eosinophils in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Malaria immunity in man and mosquito: insights into unsolved mysteries of a deadly infectious disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Protective immunity induced with malaria vaccine, RTS,S, is linked to Plasmodium falciparum circumsporozoite protein-specific CD4+ and CD8+ T cells producing IFN-gamma

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Immunization with the RTS,S/AS malaria vaccine induces IFN-γ(+)CD4 T cells that recognize only discrete regions of the circumsporozoite protein and these specificities are maintained following booster immunizations and challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Protective immunity induced with the RTS,S/AS vaccine is associated with IL-2 and TNF-α producing effector and central memory CD4 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Granulocyte-macrophage colony-stimulating factor (GM-CSF) and T-cell responses: what we do and don't know

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Development of immunity in early life

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Heterogeneity in diphtheria-tetanus-acellular pertussis vaccine-specific cellular immunity during infancy: relationship to variations in the kinetics of postnatal maturation of systemic th1 function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Could the RTS,S/AS01 meningitis safety signal really be a protective effect of rabies vaccine?

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Nonspecific effects of vaccines and the reduction of mortality in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Bacille Calmette-Guerin induces NOD2-dependent nonspecific protection from reinfection via epigenetic reprogramming of monocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Low interleukin-12 activity in severe Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Peripheral blood monocyte-to-lymphocyte ratio at study enrollment predicts efficacy of the RTS,S malaria vaccine: analysis of pooled phase II clinical trial data

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Global analyses of human immune variation reveal baseline predictors of postvaccination responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Systems Analysis of Immunity to Influenza Vaccination across Multiple Years and in Diverse Populations Reveals Shared Molecular Signatures

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

RANTES Production by Memory Phenotype T Cells Is Controlled by a Posttranscriptional, TCR-Dependent Process

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIX429

Immunogenicity of the RTS,S/AS01 malaria vaccine and implications for duration of vaccine efficacy: secondary analysis of data from a phase 3 randomised controlled trial

21 January 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5850568

Prediction of accelerated cure in Plasmodium falciparum malaria by the elevated capacity of tumor necrosis factor production.

4 November 2018

1 reference

PubMed Central

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5850568

4 November 2018

Identifiers

DOI

10.1093/CID/CIX429

1 reference

10 September 2017

0 references

1 reference